SEALSQ Launches Industry Research and Development Initiative Blending IoT with Cryptocurrency Mining
Geneva, Switzerland, April 15, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on […]
Revival Gold Announces Pricing of Previously Announced C$7 Million Brokered Equity Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 15, 2024 […]
Wrap Technologies, Inc. Provides Update on Operations and Timing to Report Financial Results
TEMPE, Ariz., April 15, 2024 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (Nasdaq: WRAP) (“Wrap” or the “Company”), the makers of […]
Sify Technologies to announce Financial Results for FY 2023-24 on April 22, 2024
CHENNAI, India, April 15, 2024 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with […]
Backblaze Enables Automated Cloud Workflows With Event Notifications
SAN MATEO, Calif., April 15, 2024 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), the leading specialized cloud storage platform, announced […]
WalkMe Cements Category Leadership with Continued AI Innovation, Industry Recognition, and Financial Growth
SAN FRANCISCO, April 15, 2024 (GLOBE NEWSWIRE) — WalkMe Ltd. (NASDAQ: WKME), a leading provider of digital adoption solutions, today […]
Castor Maritime Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement
LIMASSOL, Cyprus, April 15, 2024 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor”, or the “Company”), a diversified global […]
Gorilla Technology Lanner Launch Cutting-Edge Security Convergence Devices to Transform Cybersecurity Landscape
LONDON, April 15, 2024 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the “Company”), a global solution […]
Exela Technologies, Inc. to Host Fourth Quarter 2023 and Full Year 2023 Financial Results Conference Call
IRVING, Texas, April 15, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ:XELA, XELAP), a global business process […]
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
BOSTON, April 15, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively […]
